 |
 |
 |
 |
 |
/ / MRJMMS Home / / About MRJMMS / / Submit Manuscripts / / Call For Articles / / Editorial Board / / Archive / / Author's Guide / /
|
Other viewing option
Search Pubmed for articles by:
Rafla
S
|
Study of the diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure |
|||
|
Samir Rafla, Ali Hassan Aboelhoda, Rania
Ahmed Swied*, Azza Ahmed Khamis and |
||||
|
Alexandria
University, Faculty of Medicine, Cardiology Department, Chest
Department* and Research Institute**, Egypt Accepted March 23, 2019 |
||||
|
Abstract |
||||
|
The aim of this
study was to determine the impact of chronic obstructive
pulmonary disease treatment on the clinical condition of
patients with heart failure. Forty Patients were enrolled in
this study with chronic obstructive pulmonary disease
co-existent with heart failure (EF <50%). All patients enrolled
in this study were males (100%). Most of the studied patients
(40%) were aged between 61 and 70 years old. Definition of COPD:
when FEV1 was less than 70%. About smoking: 25 patients stopped
smoking (62.5%), and 15 patients didn’t stop smoking (37.5%).
Risk factors: 34 patients (pts) (85%) suffered from systolic
hypertension, 18 pts (45%) suffered from diabetes, and 28 pts
(70%) had dyslipidemia. All patients were smokers (97.5%) except
1 patient was passively smoking and 17 patients were NYHA class
III (42.5%), 23 patients were NYHA class II. Average weight and
height of studied patients was 88.1 ± 14.7kg and 172.5 ± 7.7cm
respectively. Mean body mass index (weight/ (height) 2) was 29.2
± 6kg/m2. ECG findings: Among studied patients, ischemic changes
in ECG were present in 37 cases (92.5%). Improvement of COPD is
associated with improvement of heart failure. Cessation of
smoking is the best marker of possible improvement of both
diseases. The use of sympathomimetics as inhalers or tablets had
no deleterious effect on cardiac function. |
Merit Research Journals© 2019 || Advertisement | Privacy policy.